Your session is about to expire
← Back to Search
Fingolimod for Cerebral Edema After Stroke (FITCH Trial)
FITCH Trial Summary
This trial will test if the drug fingolimod is safe and effective in treating primary spontaneous intracerebral hemorrhage.
FITCH Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowFITCH Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2007 Phase 4 trial • 552 Patients • NCT00110890FITCH Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have trouble swallowing or severe nausea that makes taking pills difficult.I am currently using cancer, immune-suppressing, or immune-modifying treatments.I have signed, or my legal representative has signed, the consent form to participate.I had a bleed inside the chambers of my brain without affecting the brain tissue much.I have a confirmed diagnosis of a large brain bleed not in the cerebellum.My symptoms started less than 24 hours ago, or I woke up with them today.I currently have an active viral infection.I have a specific type of heart rhythm problem.My liver is not working properly.I have a diagnosed brain blood vessel issue or recent brain bleed.I do not have a growing brain tumor causing increased pressure.I have severe brain damage with minimal consciousness.People who are in prison.You have a heart device that can't be used with the MRI scans required for the study.You have a history of traumatic brain injury leading to bleeding in the brain.Your baseline QTc interval is longer than 500 milliseconds.I have a permanent blood clotting disorder.I am under 18 years old.Your platelet count is less than 100,000 or your INR is higher than 1.4.You have a Glasgow Coma Scale (GCS) score that is higher than a certain number when you first arrive for the study.You have a historical score of 0 or 1 on the Modified Rankin Scale (mRS).I am currently taking medication for heart rhythm problems.I have been hospitalized for a serious heart condition in the last 6 months.You have a high score on the NIH Stroke Scale when you first show symptoms of a stroke.Your blood pressure should be below 200 mmHg when you join the study.
- Group 1: Fingolimod Group
- Group 2: Control Group
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does this trial offer participation for those below the age of seventy?
"To be eligible for this trial, applicants should fall between the age range of 18 to 80. There are 70 trials that specifically target those under 18 and 401 studies focusing on individuals older than 65 years old."
How many individuals are involved in this research endeavor?
"Absolutely, the information provided on clinicaltrials.gov attests to this medical study's active recruitment status. The trial was first introduced on August 7th 2020 and last modified on November 28th 2022; 10 patients are required from a single location for enrollment."
Is this trial of a kind that has not been undertaken before?
"Currently, nine trials for standard of care are running in 135 cities and forty nations. The initial study took place in 2013 under the sponsorship of Novartis Pharmaceuticals; it enrolled 220 participants before achieving its Phase 3 drug approval benchmark. In total, 18491 studies have been finalized since then."
To whom is enrollment available for this investigation?
"This study is enrolling a total of 10 participants who have intracerebral hemorrhage, hypertensive and lie between the ages 18 to 80."
What illnesses are typically managed through Standard of Care treatments?
"Carcinoma in situ, active secondary progressive multiple sclerosis (SPMS), and the general disorder of Multiple Sclerosis can all be therapeutically treated using Standard Of Care."
Are there any past examples of research on accepted therapeutic practices?
"Currently, there are 9 active clinical trials studying the Standard of Care with 3 in their third phase. Although most studies for this treatment take place near Göttingen, Campania, a total of 334 sites around the world have been conducting research on it."
Is this research endeavor currently enrolling participants?
"Affirmative. Data hosted by clinicaltrials.gov shows that this trial has been actively recruiting since it was originally posted on August 7th 2020 and most recently edited on November 28th 2022. The study is planning to enrol 10 individuals from one location."
Share this study with friends
Copy Link
Messenger